跳至主要内容
临床试验/NCT04145830
NCT04145830已完成不适用

Efficacy and Safety of UCP in the Treatment of Primary Glaucoma in China

EyeTechCare2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
2
主要终点
Efficacy endpoint : reduction of the intraocular pressure

研究概览

简要总结

To collect safety and efficacy data on Ultrasound Cycle Plasty treatment (UCP) in primary glaucoma asian patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary Open Angle and primary Angle Closure glaucoma
  • Subject where the IOP is not adequately controlled with glaucoma medication, and can not or not agree for incisional glaucoma surgery
  • IOP ≥ 21 mmHg and ≤ 40 mmHg
  • Best Corrected Visual Acuity > Hand Motion
  • Patient able and willing to sign the informed consent and complete postoperative followup requirements

排除标准

  • History of ocular or retrobulbar tumor
  • Ocular infection within 14 days prior to the procedure of Ultrasound Cyclo Plasty (UCP)
  • History of Cyclo-destructive procedures (cryotherapy, Laser transscleral cyclophotocoagulation; Laser endophotocoagulation)
  • Congenital glaucoma
  • History of ciliary body surgery or vitrectomy in the study eye
  • Ocular disease other than glaucoma that may affect assessment of visual acuity and/or IOP (choroidal hemorrhage or detachment, lens subluxation, thyroid ophthalmopathy, proliferative diabetic retinopathy, clinical significant macular edema, retinal detachment)

结局指标

主要结局

Efficacy endpoint : reduction of the intraocular pressure

时间窗: 6 months

Reduction of the intraocular pressure relative to the preoperative value at each follow-up visits in mmHg and in % of reduction

次要结局

  • Safety endpoint: rate of per operative complications(6 months)
  • Safety endpoint: rate of post-operative complications(6 months)
  • Efficacy endpoint: Number of ocular hypotensive medications(6 months)

研究者

发起方
EyeTechCare
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

UCP Glaucoma Treatment for Primary Glaucoma in China | 临床试验